News &amp; Updates

Treatment with secukinumab 300 mg significantly improves symptoms of biologic-naïve patients with psoriatic arthritis (PsA) compared with placebo, results from the CHOICE study have shown.

Secukinumab 300 mg leads to sustained improvements in PsA symptoms

12 Aug 2022

Healthy eating may prevent heart failure in men

Adherence to a healthy diet can help reduce the risk of heart failure (HF) with reduced ejection fraction (HFrEF), as seen in both the Alternative Healthy Eating Index (AHEI) and the clinically abbreviated Prime Diet Quality Score (PDQS), reveals a study.

Healthy eating may prevent heart failure in men

12 Aug 2022

Another breakthrough for HIV: Fourth patient goes into long-term remission

Hope springs yet again in the field of HIV treatment, as another HIV patient (reportedly the fourth in the world) goes into remission 3 decades following diagnosis. The patient stopped antiretroviral therapy (ART) after receiving allogeneic hematopoietic stem cell transplantation (HCT) of CCR5-Δ32/Δ32 donor cells for acute myelogenous leukaemia (AML).

Another breakthrough for HIV: Fourth patient goes into long-term remission

12 Aug 2022

$Portable, low-cost refraction device shows promise for first-level assessments$

Portable, low-cost refraction device shows promise for first-level assessments

ClickCheck, a portable and low-cost refractive error measurement device, demonstrates a high level of agreement with the standard-practice subjective refraction (SR) in terms of spherical power, according to a recent study. Nevertheless, improvements are needed to yield better cylindrical power evaluations.

Portable, low-cost refraction device shows promise for first-level assessments

Milk drinking may protect against hypertension

Increased consumption of milk helps lower blood pressure levels and reduce the risk of developing hypertension, according to a study.

Milk drinking may protect against hypertension

Time in SBP target range predicts adverse event risk in NVAF

The time in target rage (TTR) of systolic blood pressure (SBP) appears to be predictive in assessing the risk of cardiovascular death in patients with nonvalvular atrial fibrillation (NVAF), reports a recent study.

Time in SBP target range predicts adverse event risk in NVAF

Relugolix-CT benefit for endometriosis-associated pain sustained through week 104

Long-term combination therapy with relugolix plus oestradiol and norethindrone (relugolix-CT) shows sustained reductions in dysmenorrhoea and non-menstrual pelvic pain (NMPP) for up to 2 years in premenopausal women with endometriosis, according to the SPIRIT extension* study presented at ESHRE 2022.

Relugolix-CT benefit for endometriosis-associated pain sustained through week 104

Diabetes, prediabetes may signal disability in middle-aged adults

The presence of diabetes or prediabetes appears to worsen the risk of disability and mortality, reports a recent Japan study.

Diabetes, prediabetes may signal disability in middle-aged adults

11 Aug 2022

Ongoing canagliflozin treatment beneficial to diabetic patients with CKD

Treatment with the sodium‐glucose cotransporter 2 inhibitor canagliflozin protects against cardiovascular events in patients with comorbid type 2 diabetes (T2D) and chronic kidney disease (CKD), with a larger absolute benefit for total cardiovascular than first cardiovascular events, according to a post hoc analysis.

Ongoing canagliflozin treatment beneficial to diabetic patients with CKD

OSA tied to coronary collateral vessel development in STEMI patients